nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—MAPK1—epithelium—gallbladder cancer	0.00097	0.164	CbGeAlD
Isoprenaline—MAPK1—pancreas—gallbladder cancer	0.000864	0.146	CbGeAlD
Isoprenaline—PIK3R1—liver—gallbladder cancer	0.000807	0.136	CbGeAlD
Isoprenaline—PIK3R3—lymph node—gallbladder cancer	0.000724	0.122	CbGeAlD
Isoprenaline—PIK3R1—lymph node—gallbladder cancer	0.000618	0.105	CbGeAlD
Isoprenaline—MAPK1—liver—gallbladder cancer	0.00055	0.093	CbGeAlD
Isoprenaline—ADRBK1—lymph node—gallbladder cancer	0.000428	0.0723	CbGeAlD
Isoprenaline—MAPK1—lymph node—gallbladder cancer	0.000422	0.0713	CbGeAlD
Isoprenaline—CYP1A1—epithelium—gallbladder cancer	0.000266	0.0449	CbGeAlD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000223	0.000224	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ERBB3—gallbladder cancer	0.000222	0.000223	CbGpPWpGaD
Isoprenaline—MAPK1—Insulin Signaling—HRAS—gallbladder cancer	0.000221	0.000223	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—HRAS—gallbladder cancer	0.00022	0.000222	CbGpPWpGaD
Isoprenaline—MAPK1—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000219	0.000221	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—HRAS—gallbladder cancer	0.000219	0.000221	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—NRAS—gallbladder cancer	0.000219	0.00022	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ERBB3—gallbladder cancer	0.000219	0.00022	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—HRAS—gallbladder cancer	0.000218	0.000219	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000218	0.000219	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—HRAS—gallbladder cancer	0.000217	0.000218	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—EGFR—gallbladder cancer	0.000216	0.000217	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—BCL2—gallbladder cancer	0.000216	0.000217	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000213	0.000214	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—KRAS—gallbladder cancer	0.000213	0.000214	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—gallbladder cancer	0.00021	0.000211	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—ERBB2—gallbladder cancer	0.00021	0.000211	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000208	0.000209	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB4—gallbladder cancer	0.000208	0.000209	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000206	0.000207	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—gallbladder cancer	0.000205	0.000206	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—HRAS—gallbladder cancer	0.000205	0.000206	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000204	0.000205	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—HRAS—gallbladder cancer	0.000204	0.000205	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000204	0.000205	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—KRAS—gallbladder cancer	0.000204	0.000205	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—HRAS—gallbladder cancer	0.000202	0.000204	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—ERBB2—gallbladder cancer	0.000201	0.000203	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000201	0.000202	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—HRAS—gallbladder cancer	0.000201	0.000202	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000201	0.000202	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—HRAS—gallbladder cancer	0.0002	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—NRAS—gallbladder cancer	0.000197	0.000198	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ERBB3—gallbladder cancer	0.000195	0.000196	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERBB3—gallbladder cancer	0.000195	0.000196	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—BCL2—gallbladder cancer	0.000195	0.000196	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—NRAS—gallbladder cancer	0.000194	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000193	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—HRAS—gallbladder cancer	0.000193	0.000194	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—NRAS—gallbladder cancer	0.00019	0.000191	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—ERBB2—gallbladder cancer	0.000189	0.00019	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—NRAS—gallbladder cancer	0.000189	0.00019	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—KRAS—gallbladder cancer	0.000188	0.000189	CbGpPWpGaD
Isoprenaline—MAPK1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000185	0.000186	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000181	0.000182	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—HRAS—gallbladder cancer	0.000181	0.000182	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB3—gallbladder cancer	0.00018	0.000181	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB4—gallbladder cancer	0.00018	0.000181	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—EGFR—gallbladder cancer	0.000179	0.000181	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—NRAS—gallbladder cancer	0.000177	0.000178	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB4—gallbladder cancer	0.000177	0.000178	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—EGFR—gallbladder cancer	0.000177	0.000178	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000175	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—ERBB2—gallbladder cancer	0.000175	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—HRAS—gallbladder cancer	0.000174	0.000175	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—EGFR—gallbladder cancer	0.000173	0.000174	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—EGFR—gallbladder cancer	0.000172	0.000173	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—NRAS—gallbladder cancer	0.000172	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—KRAS—gallbladder cancer	0.00017	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—gallbladder cancer	0.000167	0.000168	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—KRAS—gallbladder cancer	0.000167	0.000168	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000166	0.000167	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—KRAS—gallbladder cancer	0.000164	0.000165	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—KRAS—gallbladder cancer	0.000163	0.000164	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—ERBB2—gallbladder cancer	0.000161	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—HRAS—gallbladder cancer	0.00016	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—NRAS—gallbladder cancer	0.00016	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—NRAS—gallbladder cancer	0.000158	0.000158	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—EGFR—gallbladder cancer	0.000157	0.000158	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB3—gallbladder cancer	0.000155	0.000156	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—BCL2—gallbladder cancer	0.000155	0.000156	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—gallbladder cancer	0.000155	0.000156	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—NRAS—gallbladder cancer	0.000153	0.000154	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB4—gallbladder cancer	0.000153	0.000154	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB3—gallbladder cancer	0.000153	0.000154	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—BCL2—gallbladder cancer	0.000153	0.000154	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—KRAS—gallbladder cancer	0.000153	0.000153	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ERBB2—gallbladder cancer	0.000151	0.000152	CbGpPWpGaD
Isoprenaline—CYP1A1—liver—gallbladder cancer	0.000151	0.0255	CbGeAlD
Isoprenaline—ADRBK1—Immune System—ERBB2—gallbladder cancer	0.000149	0.000149	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—KRAS—gallbladder cancer	0.000148	0.000149	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—BCL2—gallbladder cancer	0.000147	0.000148	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB4—gallbladder cancer	0.000146	0.000147	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—EGFR—gallbladder cancer	0.000145	0.000146	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—HRAS—gallbladder cancer	0.000144	0.000145	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—NRAS—gallbladder cancer	0.000144	0.000145	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—EGFR—gallbladder cancer	0.000144	0.000144	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—ERBB2—gallbladder cancer	0.000143	0.000143	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB4—gallbladder cancer	0.000142	0.000143	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—HRAS—gallbladder cancer	0.000142	0.000143	CbGpPWpGaD
Isoprenaline—MAPK1—Neuronal System—HRAS—gallbladder cancer	0.000142	0.000143	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000142	0.000142	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB4—gallbladder cancer	0.000141	0.000142	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—EGFR—gallbladder cancer	0.00014	0.00014	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ERBB2—gallbladder cancer	0.000139	0.00014	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—HRAS—gallbladder cancer	0.000139	0.00014	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HRAS—gallbladder cancer	0.000138	0.000139	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—KRAS—gallbladder cancer	0.000137	0.000138	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ERBB2—gallbladder cancer	0.000137	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—gallbladder cancer	0.000136	0.000136	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—KRAS—gallbladder cancer	0.000136	0.000136	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—NRAS—gallbladder cancer	0.000133	0.000134	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB3—gallbladder cancer	0.000132	0.000133	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—KRAS—gallbladder cancer	0.000132	0.000133	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—EGFR—gallbladder cancer	0.000131	0.000132	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—HRAS—gallbladder cancer	0.00013	0.00013	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB3—gallbladder cancer	0.000126	0.000127	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—HRAS—gallbladder cancer	0.000126	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—BCL2—gallbladder cancer	0.000126	0.000127	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—NRAS—gallbladder cancer	0.000126	0.000126	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—KRAS—gallbladder cancer	0.000124	0.000125	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—NRAS—gallbladder cancer	0.000124	0.000124	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB3—gallbladder cancer	0.000123	0.000124	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—NRAS—gallbladder cancer	0.000123	0.000124	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ERBB2—gallbladder cancer	0.000122	0.000123	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB3—gallbladder cancer	0.000122	0.000123	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERBB2—gallbladder cancer	0.000122	0.000123	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—EGFR—gallbladder cancer	0.000121	0.000122	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—NRAS—gallbladder cancer	0.00012	0.000121	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—HRAS—gallbladder cancer	0.000117	0.000117	CbGpPWpGaD
Isoprenaline—CYP1A1—lymph node—gallbladder cancer	0.000115	0.0195	CbGeAlD
Isoprenaline—PIK3R3—Signaling by GPCR—HRAS—gallbladder cancer	0.000115	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—NRAS—gallbladder cancer	0.000115	0.000115	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—EGFR—gallbladder cancer	0.000114	0.000115	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—KRAS—gallbladder cancer	0.000114	0.000115	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—NRAS—gallbladder cancer	0.000113	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB2—gallbladder cancer	0.000113	0.000113	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—EGFR—gallbladder cancer	0.000113	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HRAS—gallbladder cancer	0.000112	0.000113	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—EGFR—gallbladder cancer	0.000112	0.000113	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—NRAS—gallbladder cancer	0.000108	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—KRAS—gallbladder cancer	0.000108	0.000109	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—KRAS—gallbladder cancer	0.000106	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NRAS—gallbladder cancer	0.000106	0.000107	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—KRAS—gallbladder cancer	0.000106	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HRAS—gallbladder cancer	0.000105	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—EGFR—gallbladder cancer	0.000105	0.000105	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NRAS—gallbladder cancer	0.000104	0.000105	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—KRAS—gallbladder cancer	0.000104	0.000104	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—EGFR—gallbladder cancer	0.000103	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—NRAS—gallbladder cancer	0.000102	0.000102	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—NRAS—gallbladder cancer	9.93e-05	9.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB4—gallbladder cancer	9.91e-05	9.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—EGFR—gallbladder cancer	9.88e-05	9.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—KRAS—gallbladder cancer	9.87e-05	9.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB2—gallbladder cancer	9.75e-05	9.81e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—KRAS—gallbladder cancer	9.73e-05	9.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—HRAS—gallbladder cancer	9.72e-05	9.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—EGFR—gallbladder cancer	9.65e-05	9.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB2—gallbladder cancer	9.6e-05	9.66e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—EGFR—gallbladder cancer	9.51e-05	9.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—KRAS—gallbladder cancer	9.34e-05	9.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NRAS—gallbladder cancer	9.3e-05	9.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NRAS—gallbladder cancer	9.3e-05	9.35e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—EGFR—gallbladder cancer	9.27e-05	9.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—gallbladder cancer	9.22e-05	9.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—HRAS—gallbladder cancer	9.19e-05	9.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—KRAS—gallbladder cancer	9.12e-05	9.17e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—HRAS—gallbladder cancer	9.05e-05	9.1e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—EGFR—gallbladder cancer	9.05e-05	9.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—HRAS—gallbladder cancer	8.99e-05	9.04e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—KRAS—gallbladder cancer	8.98e-05	9.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—HRAS—gallbladder cancer	8.82e-05	8.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—KRAS—gallbladder cancer	8.76e-05	8.81e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—gallbladder cancer	8.7e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NRAS—gallbladder cancer	8.58e-05	8.63e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB3—gallbladder cancer	8.56e-05	8.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BCL2—gallbladder cancer	8.55e-05	8.6e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—KRAS—gallbladder cancer	8.55e-05	8.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EGFR—gallbladder cancer	8.48e-05	8.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EGFR—gallbladder cancer	8.47e-05	8.52e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB4—gallbladder cancer	8.44e-05	8.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HRAS—gallbladder cancer	8.39e-05	8.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB2—gallbladder cancer	8.3e-05	8.35e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HRAS—gallbladder cancer	8.27e-05	8.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB4—gallbladder cancer	8.26e-05	8.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—KRAS—gallbladder cancer	8.01e-05	8.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KRAS—gallbladder cancer	8e-05	8.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—HRAS—gallbladder cancer	7.94e-05	7.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB2—gallbladder cancer	7.9e-05	7.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EGFR—gallbladder cancer	7.82e-05	7.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HRAS—gallbladder cancer	7.75e-05	7.79e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB2—gallbladder cancer	7.71e-05	7.76e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB2—gallbladder cancer	7.67e-05	7.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HRAS—gallbladder cancer	7.63e-05	7.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—HRAS—gallbladder cancer	7.44e-05	7.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NRAS—gallbladder cancer	7.42e-05	7.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—KRAS—gallbladder cancer	7.39e-05	7.43e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NRAS—gallbladder cancer	7.31e-05	7.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB3—gallbladder cancer	7.3e-05	7.34e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—HRAS—gallbladder cancer	7.26e-05	7.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB3—gallbladder cancer	7.14e-05	7.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—gallbladder cancer	7.12e-05	7.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—NRAS—gallbladder cancer	6.92e-05	6.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HRAS—gallbladder cancer	6.81e-05	6.85e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HRAS—gallbladder cancer	6.8e-05	6.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EGFR—gallbladder cancer	6.76e-05	6.8e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EGFR—gallbladder cancer	6.66e-05	6.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KRAS—gallbladder cancer	6.38e-05	6.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NRAS—gallbladder cancer	6.32e-05	6.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—gallbladder cancer	6.3e-05	6.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KRAS—gallbladder cancer	6.29e-05	6.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HRAS—gallbladder cancer	6.28e-05	6.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NRAS—gallbladder cancer	6.01e-05	6.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—KRAS—gallbladder cancer	5.95e-05	5.99e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—NRAS—gallbladder cancer	5.89e-05	5.93e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NRAS—gallbladder cancer	5.87e-05	5.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NRAS—gallbladder cancer	5.83e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—NRAS—gallbladder cancer	5.77e-05	5.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—gallbladder cancer	5.76e-05	5.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—gallbladder cancer	5.67e-05	5.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—gallbladder cancer	5.59e-05	5.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—gallbladder cancer	5.48e-05	5.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KRAS—gallbladder cancer	5.44e-05	5.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HRAS—gallbladder cancer	5.43e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—gallbladder cancer	5.37e-05	5.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB2—gallbladder cancer	5.37e-05	5.4e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HRAS—gallbladder cancer	5.34e-05	5.38e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—gallbladder cancer	5.34e-05	5.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—gallbladder cancer	5.31e-05	5.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—gallbladder cancer	5.25e-05	5.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KRAS—gallbladder cancer	5.17e-05	5.2e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—KRAS—gallbladder cancer	5.07e-05	5.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HRAS—gallbladder cancer	5.06e-05	5.09e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KRAS—gallbladder cancer	5.05e-05	5.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KRAS—gallbladder cancer	5.02e-05	5.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—KRAS—gallbladder cancer	4.96e-05	4.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HRAS—gallbladder cancer	4.62e-05	4.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—gallbladder cancer	4.6e-05	4.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB2—gallbladder cancer	4.58e-05	4.6e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—gallbladder cancer	4.49e-05	4.51e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB2—gallbladder cancer	4.48e-05	4.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HRAS—gallbladder cancer	4.4e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HRAS—gallbladder cancer	4.31e-05	4.34e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HRAS—gallbladder cancer	4.29e-05	4.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HRAS—gallbladder cancer	4.27e-05	4.29e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HRAS—gallbladder cancer	4.22e-05	4.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NRAS—gallbladder cancer	4.09e-05	4.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—gallbladder cancer	3.72e-05	3.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KRAS—gallbladder cancer	3.52e-05	3.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NRAS—gallbladder cancer	3.48e-05	3.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NRAS—gallbladder cancer	3.41e-05	3.43e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—gallbladder cancer	3.17e-05	3.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—gallbladder cancer	3.12e-05	3.14e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—gallbladder cancer	3.1e-05	3.12e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KRAS—gallbladder cancer	3e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HRAS—gallbladder cancer	2.99e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KRAS—gallbladder cancer	2.93e-05	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—gallbladder cancer	2.66e-05	2.68e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—gallbladder cancer	2.61e-05	2.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HRAS—gallbladder cancer	2.55e-05	2.56e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HRAS—gallbladder cancer	2.49e-05	2.51e-05	CbGpPWpGaD
